Literature DB >> 17285571

Meta-analysis of mixed treatment comparisons at multiple follow-up times.

G Lu1, A E Ades, A J Sutton, N J Cooper, A H Briggs, D M Caldwell.   

Abstract

Mixed treatment comparisons (MTC) meta-analysis is a methodology for making inferences on relative treatment effects based on a synthesis of both direct and indirect evidence on multiple treatment contrasts. This is particularly useful in the context of cost-effectiveness analysis and medical decision making. Here, we extend these methods to a more complex situation where trials report results at one or more, different yet fixed, follow-up times. These methods are applied to an illustrative data set combining evidence on healing rates under six different treatments for gastro-esophageal reflux disease (GERD). A series of Bayesian hierarchical models based on piece-wise exponential hazards is developed that borrow strength across the MTC networks and also across time points. These include models for absolute and relative treatment effects, models with fixed or random effects over time, random walk models, and models with homogeneous or heterogeneous between-trials variation. The deviance information criterion (DIC) is used to guide model development and selection. Models for absolute treatment effects generate materially different rankings of the treatments than models that separate the trial-specific baselines from the relative treatment effects. The extent of between-trials heterogeneity in treatment effects depends on treatment contrast. In discussion we note that models of this type have a very wide potential application. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17285571     DOI: 10.1002/sim.2831

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  35 in total

Review 1.  Use of indirect and mixed treatment comparisons for technology assessment.

Authors:  Alex Sutton; A E Ades; Nicola Cooper; Keith Abrams
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 2.  Reasons or excuses for avoiding meta-analysis in forest plots.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Hannah R Rothstein
Journal:  BMJ       Date:  2008-06-21

Review 3.  Addressing multimorbidity in evidence integration and synthesis.

Authors:  Thomas A Trikalinos; Jodi B Segal; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

Review 4.  The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012.

Authors:  Su-Hsin Chang; Carolyn R T Stoll; Jihyun Song; J Esteban Varela; Christopher J Eagon; Graham A Colditz
Journal:  JAMA Surg       Date:  2014-03       Impact factor: 14.766

5.  Detecting outlying trials in network meta-analysis.

Authors:  Jing Zhang; Haoda Fu; Bradley P Carlin
Journal:  Stat Med       Date:  2015-04-08       Impact factor: 2.373

Review 6.  Pharmacological interventions for acute pancreatitis.

Authors:  Elisabetta Moggia; Rahul Koti; Ajay P Belgaumkar; Federico Fazio; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

7.  Network meta-analysis of randomized clinical trials: reporting the proper summaries.

Authors:  Jing Zhang; Bradley P Carlin; James D Neaton; Guoxing G Soon; Lei Nie; Robert Kane; Beth A Virnig; Haitao Chu
Journal:  Clin Trials       Date:  2013-10-03       Impact factor: 2.486

8.  Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness.

Authors:  Jing Zhang; Haitao Chu; Hwanhee Hong; Beth A Virnig; Bradley P Carlin
Journal:  Stat Methods Med Res       Date:  2015-07-28       Impact factor: 3.021

9.  Sensitivity to Excluding Treatments in Network Meta-analysis.

Authors:  Lifeng Lin; Haitao Chu; James S Hodges
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 10.  Management strategies for pancreatic pseudocysts.

Authors:  Kurinchi Selvan Gurusamy; Elena Pallari; Neil Hawkins; Stephen P Pereira; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2016-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.